Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Secondary Preventions”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT01233635
What this trial is testing

Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)

Who this might be right for
Atrial Fibrillation
University of Pittsburgh 228
Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Not applicableStudy completedNCT02658682
What this trial is testing

Secondary Prevention of Depression Applying an Experimental Attentional Bias Modification Procedure

Who this might be right for
Major Depression
University of Oslo 350
Not applicableLooking for participantsNCT05655390
What this trial is testing

IFD-SuRvivE funCtiONal effiCacy and bIologicaL corrElates (RECONCILE Study)

Who this might be right for
Suicide, AttemptedFunctioning, PsychosocialCognition+2 more
Iria Grande 120
Not applicableUnknownNCT02432469
What this trial is testing

Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence

Who this might be right for
Coronary Artery Bypass GraftingMedication AdherenceMobile Applications
China National Center for Cardiovascular Diseases 1,000
Not applicableStudy completedNCT02922959
What this trial is testing

A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses

Who this might be right for
Drug OverdoseOpioid-Related DisordersDrug Addiction+2 more
University of Cincinnati 80
Large-scale testing (Phase 3)Ended earlyNCT02313909
What this trial is testing

Rivaroxaban Versus Aspirin in Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With Recent Embolic Stroke of Undetermined Source (ESUS)

Who this might be right for
Stroke
Bayer 7,213
Large-scale testing (Phase 3)Study completedNCT00643019
What this trial is testing

Project Sexual Awareness for Everyone (SAFE)

Who this might be right for
Sexually Transmitted DiseaseSecondary PreventionBehavioral Modification+1 more
The University of Texas Health Science Center at San Antonio 800
Not applicableUnknownNCT03318744
What this trial is testing

Antiplatelet Therapy for Silent Brain Infarction

Who this might be right for
Brain Infarction
First People's Hospital of Shenyang 3,400
Not applicableStudy completedNCT02089074
What this trial is testing

Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack

Who this might be right for
Ischemic Attack, TransientStroke
Norwegian University of Science and Technology 265
Not applicableStudy completedNCT02389153
What this trial is testing

Feasability of Collaborative Care in the Secondary Prevention of Coronary Heart Disease

Who this might be right for
Coronary Heart Disease
University of Göttingen 40
Not applicableStudy completedNCT02608801
What this trial is testing

Prediction and Secondary Prevention of Fractures

Who this might be right for
Osteoporotic FracturesHip FracturesWrist Fractures+3 more
Oslo University Hospital 840
Large-scale testing (Phase 3)Study completedNCT04665830
What this trial is testing

PCSK 9 Inhibition as Secondary Prevention in Renal Transplant Patients

Who this might be right for
Kideny Transplant Recipients With High Cardiovascular Risk Score
Hamid Al-Essa Organ Transplant Center 200
Not applicableEnded earlyNCT01190072
What this trial is testing

Lipid-lowering Therapy for Secondary Prevention in Patients Undergoing Elective Percutaneous Coronary Intervention (PCI)

Who this might be right for
Coronary Artery Disease
AstraZeneca 120
Testing effectiveness (Phase 2)Looking for participantsNCT07647198
What this trial is testing

FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence

Who this might be right for
Uterine Fibroids (Leiomyoma)
Sheikh Shakhbout Medical City 240
Not applicableStudy completedNCT03859063
What this trial is testing

Long-term Follow-up After Stroke (The LAST-long Trial)

Who this might be right for
Stroke
Norwegian University of Science and Technology 301
Not applicableLooking for participantsNCT06472414
What this trial is testing

A Women-Focused Cardiovascular Rehabilitation Program on Adherence, Health Related Physical Fitness, and Quality of Life

Who this might be right for
Cardiovascular Diseases
University of Lisbon 82
Not applicableNot Yet RecruitingNCT07382414
What this trial is testing

Electronic Letters to Improve Patient Activation in IHD: The NUDGE-IHD Trial

Who this might be right for
Ischemic Heart DiseaseCoronary Artery DiseaseHypercholesterolemia+2 more
Tor Biering-Sørensen 123,000
Not applicableNot Yet RecruitingNCT07230249
What this trial is testing

Telegram Messenger Support for Smoking Cessation After Heart Attack

Who this might be right for
Myocardial Infarction (MI)Tobacco UseSmoking Cessation
ITMO University 142
Not applicableStudy completedNCT01814943
What this trial is testing

The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users

Who this might be right for
Uncomplicated Peptic Ulcer
AstraZeneca 39,000
Next Page